DIHYDROXYBUSULFAN Uses, Dosage, Side Effects and more
DIHYDROXYBUSULFAN is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. DIHYDROXYBUSULFAN has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Trade Name | DIHYDROXYBUSULFAN |
Generic | Treosulfan |
Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
Type | |
Formula | C6H14O8S2 |
Weight | Average: 278.29 Monoisotopic: 278.013009759 |
Groups | Approved, Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |